Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 245 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mineralization Clear all

Conditions: Osteoporosis
Interventions: Ronacaleret, Teriparatide, Alendronate; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 9
States / cities: Oakland, California • Palm Desert, California • Walnut Creek, California + 6 more

Conditions: Hyperparathyroidism, Secondary
Interventions: Etelcalcetide; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 891 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 101
States / cities: Birmingham, Alabama • Pine Bluff, Arkansas • Azusa, California + 86 more

Conditions: Osteoporosis, Obesity, Weight Loss
Interventions: Exercise and weight loss intervention; Other
Lead sponsor: University of North Carolina, Greensboro; Other
Eligibility: 23 Years to 40 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Indicated for EOSedge Imaging
Interventions: EOSedge imaging; Radiation
Lead sponsor: Alphatec Spine, Inc.; Industry
Eligibility: 20 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Fishers, Indiana

Conditions: Survivors of Bone Marrow Transplant, Autologous and Allogeneic
Interventions: Not listed
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 8 Years to 30 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteopetrosis
Interventions: rhPTH; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 20 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Kidney Disease Mineral and Bone Disorder
Interventions: Phosphorus Absorption Test; Other
Lead sponsor: Purdue University; Other
Eligibility: 30 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Spinal Muscular Atrophy Type 3, Ambulatory Spinal Muscular Atrophy
Interventions: Not listed
Lead sponsor: Jacqueline Montes; Other
Eligibility: 8 Years to 50 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoporosis
Interventions: Exercise intervention; Procedure
Lead sponsor: Oregon State University; Other
Eligibility: 5 Years to 10 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2008
U.S. locations: 1
States / cities: Corvallis, Oregon

Conditions: Osteoporosis
Interventions: LY2541546, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years to 85 Years · Female only
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Gainesville, Georgia • Bethesda, Maryland

Conditions: Healthy
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Menopausal Osteoporosis
Interventions: VSL#3, Placebo; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 50 Years to 65 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: End-Stage Renal Disease, Hemodialysis
Interventions: Low dialysate calcium, high dialysate calcium; Drug
Lead sponsor: Ege University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 457 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Renal Osteodystrophy
Interventions: doxercalciferol, Cholecalciferol; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 82 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Osteoporosis
Interventions: Zoledronic acid, Placebo, Teriparatide; Drug
Lead sponsor: Novartis; Industry
Eligibility: 45 Years to 89 Years · Female only
Enrollment: 412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 18
States / cities: Birmingham, Alabama • Beverly Hills, California • La Mesa, California + 15 more

Conditions: Tumor Induced Osteomalcia, Osteomalacia, Familial Tumoral Calcinosis
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 1 Day to 100 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Osteoporosis, Hypomagnesemia
Interventions: EffCaMgCit, Placebo; Drug · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Bone Mineralization Defect
Interventions: Vitamin D2; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 6 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 2
States / cities: Loma Linda, California • Los Angeles, California

Conditions: Metabolism
Interventions: Exercise; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 3 Years to 7 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: Healthy, Involutional Depression, Osteoporosis
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years and older
Enrollment: 585 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1994 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV Infections, Menopause
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years to 52 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Leukodystrophy, White Matter Disease, 4H Syndrome, Adrenoleukodystrophy, AMN, ALD, ALD (Adrenoleukodystrophy), X-linked Adrenoleukodystrophy, X-ALD, Adrenomyeloneuropathy, Aicardi Goutieres Syndrome, AGS, Alexander Disease, Alexanders Leukodystrophy, AxD, ADLD, Canavan Disease, CTX, Cerebrotendinous Xanthomatoses, Krabbe Disease, GALC Deficiency, Globoid Leukodystrophy, TUBB4A-Related Leukodystrophy, H-ABC - Hypomyelination, Atrophy of Basal Ganglia and Cerebellum, HBSL, HBSL - Hypomyelination, Brain Stem, Spinal Cord, Leg Spasticity, LBSL, Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder), Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation, ALSP, CSF1R Gene Mutation, HCC - Hypomyelination and Congenital Cataract, MLC1, Megalencephalic Leukoencephalopathy With Subcortical Cysts 1, MLD, Metachromatic Leukodystrophy, PMD, Pelizaeus-Merzbacher Disease, PLP1 Null Syndrome, PLP1 Gene Duplication &#X7C; Blood or Tissue &#X7C; Mutations, Pelizaeus-Merzbacher-Like Disease, 1, Peroxisomal Biogenesis Disorder, Zellweger Syndrome, Refsum Disease, Salla Disease, Sialic Storage Disease, Sjögren, Sjogren-Larsson Syndrome, Van Der Knapp Disease, Vanishing White Matter Disease, Charcot-Marie-Tooth, CMT, Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency, Allan-Herndon-Dudley Syndrome, Cadasil, Cockayne Syndrome, Multiple Sulfatase Deficiency, Gangliosidoses, GM2 Gangliosidosis, BPAN, Labrune Syndrome, LCC, Mucopolysaccharidoses, TBCK-Related Intellectual Disability Syndrome
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 18 Years
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Contraception, Change in Bone Mineral Density
Interventions: Drospirenone; Drug
Lead sponsor: Insud Pharma; Industry
Eligibility: 13 Years to 45 Years · Female only
Enrollment: 1,542 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 46
States / cities: Alabaster, Alabama • Birmingham, Alabama • Tucson, Arizona + 36 more

Conditions: Bone Calcification, Osteoporosis
Interventions: Lunar iXDA scan; Procedure
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Breastfeeding and Exercise for Healthy Infants and Postpartum Moms Too!

Bone Mineral Density Precision Study

Musculoskeletal Outcomes After Bone Marrow Transplant

rhPTH Therapy for Low Turnover Bone Fragility

Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease

Gait and Bone Health in SMA

Effects of Jumping on Growing Bones

A Study of LY2541546 in Women With Low Bone Mineral Density

Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density

Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women

Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

A Natural History Study of Bone and Mineral Disorders

EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy

How Bone is Made in Children Receiving Dialysis

Critical Periods of Exercise

Bone Mineral Density in Women With Major Depression

Metabolic and Psychological Changes Associated With Menopause Among Women With HIV

LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies

Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

Evaluation of Bone Length Measurement